ContextLogic Inc.
Description
ContextLogic Inc. does not have significant operations. It focuses on identifying, evaluating, and executing strategic opportunities. Previously, it was engaged in the marketplace and logistics business operations. ContextLogic Inc. was incorporated in 2010 and is headquartered in Oakland, California.
About
CEO
Mr. Rishi Bajaj
Employees
452
Instrument type
Common Stock
Sector
Consumer Cyclical
Industry
Internet Retail
MIC code
XNGS
Address
2648 International Blvd, Oakland, CA 94601, United States
×
Oscillators
No data available
Summary
No data available
Moving Averages
No data available
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 5, 2025 | — | — | — | — |
| Aug 7, 2025 | — | — | — | — |
| May 6, 2025 | — | — | — | — |
| Mar 3, 2025 | -0.01 | — | — | — |
| Nov 8, 2024 | -0.01 | -0.04 | -0.03 | 300.00% |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 1 | — | 1 |
| Average estimate | — | 0.04 | — | 0.16 |
| Low estimate | — | 0.04 | — | 0.16 |
| High estimate | — | 0.04 | — | 0.16 |
| Last year EPS | — | -2.43 | — | -2.86 |
[stock_revenue_estimate]
Growth estimates
Current qtr
101.520%
Next qtr. (Mar 2025)
101.600%
Current year
80.950%
Next year (Dec 2025)
106.640%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Analyst Ratings
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| Aug 22, 2022 |
Chardan Capital
Geulah Livshits
|
Maintains | Buy | ▼ Lowers $4 → $2.5 |
| May 17, 2022 |
Chardan Capital
Geulah Livshits
|
Maintains | Buy | ▼ Lowers $6 → $4 |
| May 10, 2022 |
JMP Securities
Silvan Tuerkcan
|
Maintains | Market Outperform | ▲ Raises $2 → $3 |
| Feb 3, 2022 |
William Blair
|
Downgrade | Market Perform | — |
| Feb 2, 2022 |
Chardan Capital
Geulah Livshits
|
Maintains | Hold | ▼ Lowers $16 → $6 |
| Dec 23, 2021 |
Chardan Capital
Geulah Livshits
|
Maintains | Buy | ▼ Lowers $20 → $16 |
| Nov 17, 2021 |
Barclays
Gena Wang
|
Maintains | Overweight | ▼ Lowers $24 → $8 |
| Nov 16, 2021 |
JMP Securities
Silvan Tuerkcan
|
Maintains | Market Outperform | ▼ Lowers $17 → $16 |
| Jun 7, 2021 |
HC Wainwright & Co.
|
Initiates | Buy | — |
| Mar 4, 2021 |
JMP Securities
|
Initiates | Outperform | — |
| May 1, 2019 |
Roth Capital
|
Initiates | Buy | — |
| Nov 19, 2018 |
Chardan Capital
|
Initiates | Buy | — |
| Nov 13, 2018 |
Chardan Capital
|
Initiates | Buy | — |
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 287.00M | 571.00M | 2.09B | 2.54B | 1.90B |
| Cost of revenue | 228.00M | 405.00M | 977.00M | 947.00M | 443.00M |
| Gross profit | 59.00M | 166.00M | 1.11B | 1.59B | 1.46B |
| Operating expense | |||||
| Research & development | 152.00M | 194.00M | 208.00M | 222.00M | 74.00M |
| Selling general and admin | 235.00M | 370.00M | 1.27B | 2.00B | 1.53B |
| Other operating expenses | — | — | — | — | — |
| Operating income | -328.00M | -398.00M | -367.00M | -631.00M | -144.00M |
| Non operating interest income | |||||
| Income | 16.00M | 15.00M | — | — | — |
| Expense | — | — | — | — | — |
| Other income expense | — | — | — | -110.00M | -3.00M |
| Pretax income | -312.00M | -383.00M | -351.00M | -743.00M | -128.00M |
| Tax provision | 5.00M | 1.00M | 10.00M | 2.00M | 1.00M |
| Net income | -317.00M | -384.00M | -361.00M | -745.00M | -129.00M |
| Basic EPS | -13.36 | -17.13 | -17.10 | -176.10 | -7.19 |
| Diluted EPS | -13.36 | -17.13 | -17.10 | -176.10 | -7.19 |
| Basic average shares | 23.73M | 22.42M | 20.97M | 4.23M | 18.92M |
| Diluted average shares | 23.73M | 22.42M | 20.97M | 4.23M | 18.92M |
| EBITDA | -324.00M | -392.00M | -358.00M | -509.00M | -131.00M |
| Net income from continuing op. | -317.00M | -384.00M | -361.00M | -745.00M | -129.00M |
| Minority interests | — | — | — | — | — |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 423.00M | 799.00M | 1.28B | 2.40B | 1.37B |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 238.00M | 506.00M | 1.01B | 1.97B | 744.00M |
| Other short term investments | 144.00M | 213.00M | 150.00M | 164.00M | 300.00M |
| Accounts receivable | — | — | — | — | — |
| Other receivables | 7.00M | 14.00M | 17.00M | 83.00M | 95.00M |
| Inventory | — | — | — | — | — |
| Prepaid assets | — | — | 48.00M | 102.00M | 95.00M |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | 21.00M | 44.00M | 48.00M | 102.00M | 95.00M |
| Non current assets | |||||
| Properties | 9.00M | 18.00M | 35.00M | 68.00M | 41.00M |
| Land and improvements | — | — | — | — | — |
| Machinery furniture equipment | — | — | — | 26.00M | 28.00M |
| Construction in progress | — | — | — | — | — |
| Leases | — | — | — | 29.00M | 28.00M |
| Accumulated depreciation | — | — | — | -30.00M | -22.00M |
| Goodwill | — | — | — | — | — |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | — | — | — | — | — |
| Investments and advances | — | — | 17.00M | 4.00M | 34.00M |
| Other non current assets | 4.00M | 4.00M | 7.00M | 11.00M | 23.00M |
| Total liabilities | 206.00M | 322.00M | 465.00M | 1.37B | 2.81B |
| Current liabilities | |||||
| Accounts payable | 30.00M | 53.00M | 67.00M | 434.00M | 171.00M |
| Accrued expenses | 66.00M | 97.00M | 123.00M | 299.00M | 188.00M |
| Short term debt | — | — | — | — | — |
| Deferred revenue | 12.00M | 18.00M | 25.00M | 37.00M | 24.00M |
| Tax payable | 12.00M | 15.00M | 26.00M | 31.00M | — |
| Pensions | — | — | — | — | — |
| Other current liabilities | 2.00M | 6.00M | 23.00M | 77.00M | 97.00M |
| Non current liabilities | |||||
| Long term debt | 6.00M | 13.00M | 16.00M | 38.00M | 42.00M |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | — | — | — | — | — |
| Derivative product liabilities | — | — | — | — | 127.00M |
| Other non current liabilities | 4.00M | — | — | — | — |
| Shareholders equity | |||||
| Common stock | — | — | — | — | — |
| Retained earnings | -3.25B | -2.93B | -2.55B | -2.18B | -1.44B |
| Other shareholders equity | -7.00M | -5.00M | 3.00M | 1.00M | — |
| Total shareholders equity | 217.00M | 477.00M | 818.00M | 1.03B | -1.44B |
| Additional paid in capital | 3.47B | 3.41B | 3.36B | 3.21B | — |
| Treasury stock | — | — | — | — | — |
| Minority interest | — | — | — | — | — |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | -317.00M | -384.00M | -361.00M | -745.00M | -129.00M | -208.00M | -207.00M |
| Depreciation | 4.00M | 6.00M | 9.00M | 12.00M | 10.00M | 8.00M | 4.00M |
| Deferred Taxes | — | — | — | — | — | — | — |
| Stock-Based Compensation | 64.00M | 72.00M | 141.00M | 390.00M | 2.00M | 2.00M | 8.00M |
| Other Non-Cash Items | 4.00M | 6.00M | 15.00M | 8.00M | 6.00M | -9.00M | 3.00M |
| Accounts Receivable | 6.00M | 3.00M | 66.00M | 12.00M | -2.00M | 13.00M | -59.00M |
| Accounts Payable | -22.00M | -13.00M | -367.00M | 263.00M | 40.00M | 2.00M | 85.00M |
| Other Assets & Liabilities | -6.00M | -11.00M | -39.00M | -7.00M | 7.00M | 2.00M | -6.00M |
| Operating Cash Flow | -267.00M | -321.00M | -536.00M | -67.00M | -66.00M | -190.00M | -172.00M |
| Investing Activities | |||||||
| Capital Expenditures | -3.00M | -2.00M | -2.00M | -2.00M | -11.00M | -20.00M | -12.00M |
| Net Intangibles | — | — | — | — | — | — | — |
| Net Acquisitions | — | — | — | — | — | — | — |
| Purchase of Investments | -313.00M | -368.00M | -299.00M | -266.00M | -485.00M | -366.00M | -343.00M |
| Sale of Investments | 390.00M | 321.00M | 298.00M | 433.00M | 456.00M | 361.00M | 163.00M |
| Investing Cash Flow | 74.00M | -47.00M | -3.00M | 165.00M | -40.00M | -16.00M | -192.00M |
| Financing Activities | |||||||
| Long-Term Debt Issuance | — | — | — | — | — | — | — |
| Long-Term Debt Payments | — | — | — | — | — | — | — |
| Other Financing Charges | -5.00M | -23.00M | -6.00M | -5.00M | — | 1.00M | -1.00M |
| Financing Cash Flow | -5.00M | -23.00M | -6.00M | 1.05B | 132.00M | -5.00M | 177.00M |
| Other Cash Details | |||||||
| End Cash Position | 238.00M | 513.00M | 1.02B | 1.97B | 754.00M | 722.00M | 837.00M |
| Income Tax Paid | 1.00M | 6.00M | 10.00M | 1.00M | — | — | — |
| Interest Paid | — | — | — | — | — | — | — |
| Free Cash Flow | -344.00M | -424.00M | -953.00M | -2.00M | -71.00M | -114.00M | 134.00M |
Error: Invalid format in Holders JSON file.
Article
ContextLogic Inc. Reports Third-Quarter 2024 Financial Results
OAKLAND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and nine months ended September 30, 2024.
GlobeNewsWire
Neutral
Nov 7, 2024
Article
ContextLogic Inc. Reports Second-Quarter Financial Results
OAKLAND, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and six months ended June 30, 2024.
GlobeNewsWire
Neutral
Aug 8, 2024
Article
Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics
WILMINGTON, Del.--( BUSINESS WIRE )--Alexion, AstraZeneca Rare Disease, today announced the completion of its acquisition of LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine company.
Business Wire
Neutral
Nov 16, 2022